Trending

EULAR

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

Swiss pharma hopes to bounce back from Q1 sales disappointment

X

Amid tough competition, Novartis makes case for rheumatology drug Cosentyx

https://pharmaphorum.com/news/novartis-eric-hughes-cosentyx-secukinumab/

Russian rival to GSK/Janssen’s RA drug revealed

Russian rival to GSK/Janssen’s RA drug revealed

R-Pharm has a mid-stage rival.

X

Russian rival to GSK/Janssen’s RA drug revealed

https://pharmaphorum.com/news/russian-rival-gskjanssens-ra-drug-revealed/

Janssen’s RA candidate among hot topics at EULAR

Janssen’s RA candidate among hot topics at EULAR

But attendees warned to expect “oceanic” weather.

X

Janssen’s RA candidate among hot topics at EULAR

https://pharmaphorum.com/news/janssens-ra-candidate-among-hot-topics-eular/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com